Sterling

Novavax vs GSK vs Pfizer and 1 More Revenue Comparison

Compare financial metrics side-by-side using real SEC EDGAR data

Novavax logo
Novavax
GSK logo
GSK
Pfizer logo
Pfizer
Merck & Co. logo
Merck & Co.

Revenue Comparison

Chart: Revenue Comparison. Values in USD billions. In Q3 2026: Novavax 0.068, GSK 11.109, Pfizer 16.583, Merck & Co. 18.085.

Latest Quarter Comparison

Table: Latest Quarter Comparison. 15 rows across Metric, Novavax, GSK, Pfizer, Merck & Co..
MetricNovavaxGSKPfizerMerck & Co.
Market Cap$1.32B$97.90B$160.37B$343.93B
Revenue$68.00M$11.11B$16.58B$18.09B
Cost of Revenue$23.00M$2.84B$4.03B$4.89B
Gross Profit$45.00M$8.27B$12.55B$13.19B
Operating Income$-31.00M$3.21B$3.67B$5.59B
Net Income$-31.00M$1.93B$3.24B$5.07B
R&D Expense$52.00M$2.34B$3.02B$4.54B
Earnings Per Share-$0.19$0.96$0.56$2.04
Gross Margin65.6%74.5%75.7%73.0%
Operating Margin-45.8%28.9%22.1%30.9%
Net Profit Margin-45.9%17.4%19.6%28.0%
Free Cash Flow$-95.00M$3.04B$4.80B$5.52B
Cumulative Free Cash Flow$-2.98B$160.25B$361.51B$255.22B
Operating Cash Flow$-94.00M$3.51B$5.38B$6.56B
Cash & Equivalents$222.00M$3.72B$1.82B$9.55B

Ask Sterling

Register for a premium account to gain access to Sterling AI.

Get Started

Things you can ask Sterling:

Summarize Tesla's latest earnings reportWhy did NVIDIA's margins expand?Compare Apple vs Microsoft's cash flowWhat's driving EV industry growth?
Menu
Favorites